Acute promyelocytic leukemia (APL) is characterized by a reciprocal translocation t(15;17)(q22;q21) leading to the disruption of Promyelocytic leukemia (PML) and Retionic Acid Receptor Alpha (RARA) followed by reciprocal PML-RARA fusion in 90% of the cases. Fluorescence in situ hybridization (FISH) has overcome the hurdles of unavailability of abnormal and/or lack of metaphase cells, and detection of cryptic, submicroscopic rearrangements. In the present study, besides diagnostic approach we sought to analyze these cases for identifi cation and characterization of cryptic rearrangements, deletion variants and unknown RARA translocation variants by application of D-FISH and RARA break-apart probe strategy on interphase and metaphase cells in a large series of 200 cases of APL. Forty cases (20%) had atypical PML-RARA and/or RARA variants. D-FISH with PML/RARA probe helped identifi cation of RARA insertion to PML. By application of D-FISH on metaphase cells, we documented that translocation of 15 to 17 leads to 17q deletion which results in loss of reciprocal fusion and/or residual RARA on der(17). Among the complex variants of t(15;17), PML-RARA fusion followed by residual RARA insertion closed to PML-RARA on der(15) was unique and unusual. FISH with break-apart RARA probe on metaphase cells was found to be a very effi cient strategy to detect unknown RARA variant translocations like t(11;17)(q23;q21), t(11;17)(q13;q21) and t(2;17)(p21;q21). These fi ndings proved that D-FISH and break-apart probe strategy has potential to detect primary as well as secondary additional aberrations of PML, RARA and other additional loci. The long-term clinical follow-up is essential to evaluate
Introduction
Acute promyelocytic leukemia (APL) is characterized by reciprocal translocation t(15;17)(q22;q21) leading to the disruption of PML and RARA followed by a reciprocal PML-RARA fusion in 90% of the cases. [1] [2] [3] [4] [5] [6] [7] Molecular cytogenetics like interphase fl uorescence in situ hybridization (FISH) has overcome the hurdles of unavailability of abnormal and/or lack of metaphase cells, detection of cryptic, submicroscopic rearrangements due to insertion events, identifi cation of complex variants as well as RARA translocation variants that has diagnostic utility in the diagnosis as well as management of disease. [6, [8] [9] [10] [11] [12] Besides diagnostic approach, we sought to analyze these cases for identifi cation and characterization of cryptic rearrangements, deletion variants and unknown RARA translocation variants by application of D-FISH and RARA break-apart probe strategy on metaphase cells in APL at diagnosis.
Materials and Methods
The present study included 200 APL patients who belonged to the age group 1-70 years. Patients who were diagnosed by standard morphology criteria and immunophenotype criteria, between January 2005 and December 2010, were enrolled in this study. Molecular
Cytogenetics-Fluorescence-in-situ hybridization (FISH)
is part of the routine diagnostic criteria and also for monitoring treatment for evaluation of cytogenetic remission.
Cytogenetic preparation was carried out on bone marrow aspirate and occasionally on peripheral blood. 
Results and Discussion
Molecular characterization and interpretation of PML-RARA fusion positive cases by D-FISH using PML/ RARA probe is given in Table 1 and Figure 1 . Figure 1b , Table 1 ].
In six out of nine cases with 1R 1G 1F signal pattern in metaphase cells, there was a lack of reciprocal fusion on der (17) . An inverted DAPI image revealed normal appearing chromosome 17 in four cases which indicated interstitial insertion of whole RARA into PML on der (15) . This is consistent with masked PML-RARA, a common event known to occur in APL with t(15;17) negative cases by conventional karyotyping. [9, 10, 13, 14] In three cases, der (17) of APL patients. The poor morphology of metaphase cells probably masks the abnormal 17 by conventional cytogenetics as discussed by others. [7, 15] The signal pattern 1R 2G 1F observed in three cases was detected on interphase cells due to unavailability of abnormal metaphase cells. The nonreciprocal fusion pattern with the presence of residual RARA probably suggests deletion of 15qter region. Loss of DNA material on 9q is very common in Chronic Myeloid Leukemia (CML) cases. [16, 17] We have also detected nonreciprocal BCR-ABL with 9q deletion/res ABL deletion/res BCR deletion in a large CML series of 2000 cases (our unpublished data). Our vast experience in various hematological malignancies like Acute Lymphoblastic Leukemia (ALL) [18] [19] [20] in lymphoma [21] which support the notion that genomic deletions followed by translocations are common events in hematological malignancies.
Metaphase analysis of cases with 1R 1G 3F helped identifi cation of duplication of PML-RARA on both arms of 17q as a result of i(17q) in three cases [ Figure 1d ]. Additional copies of PML-RARA due to i(17q) or duplication of der (17) are not uncommon events in APL. [7, 22] An i(17q) with duplication of PML-RARA is similar to Ph duplication as a result of either i(ph) or two separate copies of Ph chromosome in Chronic Myeloid Leukemia -Accelerated Phase (CML-AP) or CML-BP. [6, 23] D-FISH strategy was found to be very effi cient to detect complex variant translocation of PML-RARA. We identifi ed six cases with 2R 2G 1F signal pattern. We could characterize one variant with PML-RARA on der(15) at locus 15q22 as result of translocation and additionally insertion of residual RARA at locus 15q15 next to PML-RARA and residual RARA on der (17) [ Figure 1e ]. The overall signal pattern on metaphase cell was interpreted as two sequential events: first t(15;17): PML-RARA on der(15), followed by an insertion of residual RARA on der (15) . Such atypical PML, RARA rearrangement was very unusual, and not reported before to our knowledge. The complex variants involving 15, 17 and a third chromosome have been reported. [11, 13, 15] Review of literature on deletion variants or cryptic masked/complex variants of PML-RARA revealed very few reports. Studies of Thomas et al. (11) in 52 cases of APL showed 6% incidence. Our large series data revealed 14% incidence of deletion/complex variants of PML-RARA.
Six cases with 2R 1G 2 dimG signal pattern revealed RARA translocation with partner chromosome other than 15 [ Table 1 ]. Application of FISH with dual color RARA break-apart probe on interphase cells showed 1R 1G 1Y signal. The analysis of metaphase cells identifi ed chromosome 11 as a partner chromosome in four cases. Inverted DAPI image helped in the identifi cation of break point at band 11q23, a locus of PLZF in two cases [ Figure 1f ] and band 11q13, a locus of nuclear mitotic apparatus (NUMA) (two cases) [ Figure 1g ]. Among the variant RARA translocations, translocations involving 11q23 and 11q13 locus are frequent and found to show resistance to retinoid therapy. [24] [25] [26] Besides t(11;17(q13;q21) and t(11;17)(q23;q21), t(2;17) (p21;q21) was identifi ed in our series [ Figure 1h ]. To our knowledge, t(2;17)(p21;q21) was not reported before in APL. The incidence of RARA variant translocations in our series of APL was 3% which is similar (1-2%) to those reported in other geographic areas. [5, 7, 25] In conclusion, D-FISH strategy was found to be very effi cient, sensitive and reliable approach in comparison with conventional cytogenetics in the diagnosis of APL. In the present large-scale study, it helped in the identifi cation of cryptic rearrangements like insertion of RARA to PML. We also documented that translocation of 15 to 17 leads to 17q deletion which results in loss of reciprocal fusion and/or residual RARA on der (17) . Apart from deletion variants, complex variant translocations of PML-RARA could also be detected by D-FISH interphase and metaphase approach. Among complex variants, t(15;17) followed by residual RARA insertion was unique and unusual. Combination of D-FISH and break-apart RARA probe proved its ability to detect unknown variant RARA translocations other than t(11;17) like t(11;17)(q23;q21), t(11;17)(q13;q21) and t(2;17) (p21;q21). The understanding of underlying biology will be able to focus upon the pathogenesis with respect to resistance to All-Trans-Retinoic-Acid (ATRA) therapy in APL. These fi ndings proved that D-FISH and break-apart probe strategy have the potential to detect primary as well as secondary additional aberrations of PML and RARA and other additional loci. The long-term clinical follow-up is essential to evaluate the clinical importance of these fi ndings. Also, additional large-scale studies are awaited to support the clinical and biological signifi cance.
